QuartzBio SolveBio PR Social Image 20230123

QuartzBio, a Part of Precision for Medicine, Acquires SolveBio and Expands Software-as-a-Service (SaaS) Data Management Solutions for Clinical Research & Development

Precision for Medicine, the first global, precision medicine, clinical research services organization today announced the strategic acquisition of SolveBio, which will now fall under the QuartzBio, part of Precision for Medicine brand and product portfolio.   Read More →
Webinar: Clinical Sample Chaos – Tracking and Reporting Metrics Across Clinical Programs

Webinar: Clinical Sample Chaos – Tracking and Reporting Metrics Across Clinical Programs

Date: Wednesday, February 1, 2023

Time: 12 pm ET | 9 am PT | 6 pm CET

Duration: 30 minutes

Register for the Webinar:

Complex sample operations, disparate vendors, inconsistent metadata across labs are common challenges sponsors face when keeping track of samples across clinical programs. ​

Join our webinar to learn how sponsor teams are creating consistent, portfolio-level approaches for tracking sample status and location and uncovering insights into vendor/site/country-level performance.

Read More →
Connecting Raw, Processed, and Ancillary Data with a Biomarker Data Management Solution

Connecting Raw, Processed, and Ancillary Data with a Biomarker Data Management Solution

Translational and clinical teams spend more than 70% of their time managing, cleaning, and harmonizing data generated in biomarker-rich clinical programs. In a recent webinar, Adam Brown demonstrated how the QuartzBio® enterprise Biomarker Data Management (eBDM) solution addresses one set of frequently intractable challenges: connecting raw, processed, and ancillary data across multiple clinical studies. Read More →
ICF Codification QuartzBio

How a Flexible Approach to ICF Codification Reduces Complexity

Biospecimens collected as part of biomarker-informed clinical programs are precious resources for precision medicine research and development (R&D). However, the complexity of tracking and linking informed consent data at the sample and derivative levels limits the use of these biospecimens. In this post, we’ll explore how clinical teams can benefit from QuartzBio’s flexible approach to ICF codification to reduce complexity, gain more value from their stored samples, and help turn their biorepositories into drug development engines. Read More →